Log in to save to my catalogue

Cardio-renal benefits of sodium–glucose co-transporter 2 inhibitors in heart failure with reduced ej...

Cardio-renal benefits of sodium–glucose co-transporter 2 inhibitors in heart failure with reduced ej...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2552056099

Cardio-renal benefits of sodium–glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence

About this item

Full title

Cardio-renal benefits of sodium–glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence

Publisher

England: Oxford University Press

Journal title

European heart journal. Cardiovascular pharmacotherapy, 2022-05, Vol.8 (3), p.311-321

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Abstract
The heart and the kidneys are closely interconnected, and disease in one organ system can lead to disease in the other. This interdependence is illustrated in heart failure with reduced ejection fraction (HFrEF), where worsening heart failure (HF) can lead to renal dysfunction and vice versa. Further complicating this situation is the f...

Alternative Titles

Full title

Cardio-renal benefits of sodium–glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2552056099

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2552056099

Other Identifiers

ISSN

2055-6837

E-ISSN

2055-6845

DOI

10.1093/ehjcvp/pvab056

How to access this item